{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T02:15:30Z","timestamp":1768097730469,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,8,17]],"date-time":"2009-08-17T00:00:00Z","timestamp":1250467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/aps.2009.114","type":"journal-article","created":{"date-parts":[[2009,8,17]],"date-time":"2009-08-17T08:22:36Z","timestamp":1250497356000},"page":"1253-1261","source":"Crossref","is-referenced-by-count":7,"title":["Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis"],"prefix":"10.1038","volume":"30","author":[{"given":"Jiang-tao","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao-wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,17]]},"reference":[{"key":"BFaps2009114_CR1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206\u201352.","journal-title":"Hypertension"},{"key":"BFaps2009114_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/hy09t1.092927","volume":"38 (Part 2)","author":"MI Phillips","year":"2001","unstructured":"Phillips MI . Gene therapy for hypertension: the preclinical data. Hypertension 2001; 38 (Part 2): 543\u20138.","journal-title":"Hypertension"},{"key":"BFaps2009114_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/sj.gt.3301109","volume":"7","author":"PE Monahan","year":"2000","unstructured":"Monahan PE, Samulski RJ . AAV vectors: is clinical success on the horizon? Gene Ther 2000; 7: 24\u201330.","journal-title":"Gene Ther"},{"key":"BFaps2009114_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/gt.2008.68","volume":"15","author":"C Mueller","year":"2008","unstructured":"Mueller C, Flotte TR . Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 2008; 15: 858\u201363.","journal-title":"Gene Ther"},{"key":"BFaps2009114_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1113\/expphysiol.2004.028464","volume":"90","author":"J Chao","year":"2005","unstructured":"Chao J, Chao L . Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol 2005; 90: 291\u20138.","journal-title":"Exp Physiol"},{"key":"BFaps2009114_CR6","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/sj.gt.3302294","volume":"11","author":"T Wang","year":"2004","unstructured":"Wang T, Li H, Zhao C, Chen C, Li J, Chao J, et al. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Gene Ther 2004; 11: 1342\u201350.","journal-title":"Gene Ther"},{"key":"BFaps2009114_CR7","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1111\/j.1745-7254.2007.00677.x","volume":"28","author":"T Wang","year":"2007","unstructured":"Wang T, Hou L, Liu Z, Wang Y, Chen C, Xiao X, et al. Intramuscular delivery of raav-mediated kallikrein gene reduces hypertension and prevents cardiovascular injuries in model rats. Acta Pharmacol Sin 2007; 28: 1898\u20131906.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2009114_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1745-7254.2008.00815.x","volume":"29","author":"J Yan","year":"2008","unstructured":"Yan J, Wang T, Li J, Xiao X, Wang D . Recombinant adeno-associated virus-mediated human kallikrein gene therapy prevents high-salt diet-induced hypertension without effect on basal blood pressure. Acta Pharmacol Sin 2008; 29: 808\u201314.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2009114_CR9","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","volume":"72","author":"X Xiao","year":"1998","unstructured":"Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224\u201332.","journal-title":"J Virol"},{"key":"BFaps2009114_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bcp.2008.09.027","volume":"77","author":"II Kramarenko","year":"2009","unstructured":"Kramarenko II, Bunni MA, Morinelli TA, Raymond JR, Garnovskaya MN . Identification of functional bradykinin B2 receptors endogenously expressed in HEK293 cells. Biochem Pharmacol 2009; 77: 269\u201376.","journal-title":"Biochem Pharmacol"},{"key":"BFaps2009114_CR11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1161\/01.HYP.26.4.642","volume":"26","author":"P Hamet","year":"1995","unstructured":"Hamet P, Richard L, Dam TV, Teiger E, Orlov SN, Gaboury L, et al. Apoptosis in target organs of hypertension. Hypertension 1995; 26: 642\u20138.","journal-title":"Hypertension"},{"key":"BFaps2009114_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0008-6363(03)00498-X","volume":"59","author":"A Gonzalez","year":"2003","unstructured":"Gonzalez A, Fortuno MA, Querejeta R, Ravassa S, Lopez B, Lopez N, et al. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 2003; 59: 549\u201362.","journal-title":"Cardiovasc Res"},{"key":"BFaps2009114_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1006\/jmcc.1996.0333","volume":"29","author":"J Kajstura","year":"1997","unstructured":"Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997; 29: 859\u201370.","journal-title":"J Mol Cell Cardiol"},{"key":"BFaps2009114_CR14","doi-asserted-by":"publisher","first-page":"H1635","DOI":"10.1152\/ajpheart.00984.2001","volume":"282","author":"QN Diep","year":"2002","unstructured":"Diep QN, El Mabrouk M, Yue P, Schiffrin EL . Effect of at1 receptor blockade on cardiac apoptosis in angiotensin ii-induced hypertension. Am J Physiol Heart Circ Physiol 2002; 282: H1635\u201341.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFaps2009114_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/hy0102.100788","volume":"39","author":"A Gonzalez","year":"2002","unstructured":"Gonzalez A, Lopez B, Ravassa S, Querejeta R, Larman M, Diez J, et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002; 39: 75\u201380.","journal-title":"Hypertension"},{"key":"BFaps2009114_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1124\/jpet.107.124859","volume":"323","author":"E Messadi-Laribi","year":"2007","unstructured":"Messadi-Laribi E, Griol-Charhbili V, Pizard A, Vincent MP, Heudes D, Meneton P, et al. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia. J Pharmacol Exp Ther 2007; 323: 210\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps2009114_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.intimp.2007.07.022","volume":"8","author":"D Westermann","year":"2008","unstructured":"Westermann D, Schultheiss HP, Tsch\u00f6pe C . New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration. Int Immunopharmacol 2008; 8: 148\u201354.","journal-title":"Int Immunopharmacol"},{"key":"BFaps2009114_CR18","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.1074\/jbc.M407179200","volume":"280","author":"H Yin","year":"2005","unstructured":"Yin H, Chao L, Chao J . Kallikrein\/Kinin protects against myocardial apoptosis after ischemia\/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad{middle dot}14-3-3 signaling pathways. J Biol Chem 2005; 280: 8022\u201330.","journal-title":"J Biol Chem"},{"key":"BFaps2009114_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1440-1681.2008.04902.x","volume":"35","author":"E Messadi-Laribi","year":"2008","unstructured":"Messadi-Laribi E, Griol-Charhbili V, Gaies E, Vincent MP, Heudes D, Meneton P, et al. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice. Clin Exp Pharmacol Physiol 2008; 35: 489\u201393.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFaps2009114_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1515\/BC.2006.085","volume":"387","author":"J Chao","year":"2006","unstructured":"Chao J, Bledsoe G, Yin H, Chao L . The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biol Chem 2006; 387: 665\u201375.","journal-title":"Biol Chem"},{"key":"BFaps2009114_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/ndt\/gfi225","volume":"21","author":"G Bledsoe","year":"2006","unstructured":"Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, et al. Kallikrein\/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Neprol Dial Transplant 2006; 21: 624\u201333.","journal-title":"Neprol Dial Transplant"},{"key":"BFaps2009114_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/hum.2007.138","volume":"19","author":"L Tu","year":"2008","unstructured":"Tu L, Xu X, Wan H, Zhou C, Deng J, Xu G, et al. Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats. Hum Gene Ther 2008; 19: 318\u201330.","journal-title":"Hum Gene Ther"},{"key":"BFaps2009114_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/hy09t1.096249","volume":"38","author":"HD Intengan","year":"2001","unstructured":"Intengan HD, Schiffrin EL . Vascular remodeling in hypertension: Roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38: 581\u20137.","journal-title":"Hypertension"},{"key":"BFaps2009114_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.RES.87.3.179","volume":"87","author":"K Irani","year":"2000","unstructured":"Irani K . Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000; 87: 179\u201383.","journal-title":"Circ Res"},{"key":"BFaps2009114_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.RES.79.4.748","volume":"79","author":"MJ Pollman","year":"1996","unstructured":"Pollman MJ, Yamada T, Horiuchi M, Gibbons GH . Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res 1996; 79: 748\u201356.","journal-title":"Circ Res"},{"key":"BFaps2009114_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1073\/pnas.93.1.156","volume":"93","author":"T Yamada","year":"1996","unstructured":"Yamada T, Horiuchi M, Dzau VJ . Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996; 93: 156\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFaps2009114_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1096\/fasebj.14.7.991","volume":"14","author":"M Cattaruzza","year":"2000","unstructured":"Cattaruzza M, Dimigen C, Ehrenreich H, Hecker M . Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells. FASEB J 2000; 14: 991\u20138.","journal-title":"FASEB J"},{"key":"BFaps2009114_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5483\/BMBRep.2008.41.1.011","volume":"41","author":"SY Jeong","year":"2008","unstructured":"Jeong SY, Seol DW . The role of mitochondria in apoptosis. BMB Rep 2008; 41: 11\u201322.","journal-title":"BMB Rep"},{"key":"BFaps2009114_CR29","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1038\/onc.2008.297","volume":"27","author":"J Li","year":"2008","unstructured":"Li J, Yuan J . Caspases in apoptosis and beyond. Oncogene 2008; 27: 6194\u2013206.","journal-title":"Oncogene"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2009114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2009114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2009114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:20:52Z","timestamp":1684412452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2009114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,17]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BFaps2009114"],"URL":"https:\/\/doi.org\/10.1038\/aps.2009.114","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,17]]}}}